Adaptin Bio, Inc. Proceeds from Notes Payable
Adaptin Bio, Inc. (APTN) reported Proceeds from Notes Payable of $1.00 million for the 12-month period ending 2024-12-31, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-08-28
- Adaptin Bio, Inc. proceeds from notes payable for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Adaptin Bio, Inc. proceeds from notes payable for the quarter ending 2024-09-30 was $25.19K, a 11.63% increase year-over-year.
- Adaptin Bio, Inc. proceeds from notes payable for the quarter ending 2024-06-30 was $222.54K.
- Adaptin Bio, Inc. proceeds from notes payable for the quarter ending 2024-03-31 was $90.00K.
- Adaptin Bio, Inc. proceeds from notes payable for fiscal 2023 was $80.92K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 9 month as first filed | Proceeds from Notes Payable 10 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $25.19K derived: sum of 2 quarters · filed 2026-08-28 | $247.73K derived: sum of 3 quarters · filed 2026-08-28 | $1.00M S-1 · filed 2026-08-28 | $57.95K 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $25.19K 10-Q · filed 2024-11-14 | $247.73K derived: sum of 2 quarters · filed 2025-08-14 | $1.00M 10-Q · filed 2025-11-14 | $56.55K 10-Q · filed 2024-11-14 | $396.08K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-06-30 | $222.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $312.54K 10-Q · filed 2025-08-14 | $31.35K 10-Q · filed 2024-08-14 | $370.89K derived: sum of 3 quarters · filed 2025-08-14 | $393.46K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $90.00K 10-Q · filed 2025-05-15 | $148.35K derived: sum of 2 quarters · filed 2025-05-15 | $170.91K derived: sum of 3 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $58.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $80.92K derived: sum of 2 quarters · filed 2024-11-14 | $80.92K 10-K · filed 2024-04-01 | |||||
| 2023-09-30 | $22.57K 10-Q · filed 2024-11-14 | $22.57K 10-Q · filed 2024-11-14 | ||||||
| 2022-12-31 | $304.00 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | $304.00 10-Q · filed 2023-11-14 |